New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:04 EDTRENT, SSW, ESI, IBM, STO, PXD, FRX, TTEK, TOT, MXWL, AGN, WBKOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Buy from Neutral at SunTrust... American Express (AXP) upgraded to Positive from Neutral at Susquehanna ... Forest Labs (FRX) upgraded to Outperform from Neutral at Credit Suisse... ITT Educational (ESI) upgraded to Buy from Neutral at BofA/Merrill... Maxwell (MXWL) upgraded to Overweight from Neutral at Piper Jaffray... Pioneer Natural (PXD) upgraded to Buy from Hold at Stifel... Seaspan (SSW) upgraded to Hold from Sell at Stifel... Statoil (STO) upgraded to Buy from Hold at Deutsche Bank... Total (TOT) upgraded to Buy from Neutral at Citigroup... Rentrak (RENT) upgraded to Market Perform from Underweight at Albert Fried... IBM (IBM) upgraded to Buy from Outperform at CLSA... Tetra Tech (TTEK) upgraded to Overweight from Equal Weight at Stephens... Westpac Banking (WBK) upgraded to Neutral from Sell at Goldman.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
November 19, 2015
06:46 EDTAGNCiti not seeing how Treasury can stop Pfizer, Allergan deal
Citi analyst Liav Abraham says he struggles to see what the Treasury can do to stop Pfizer's (PFE) potential acquisition of Allergan (AGN). The Treasury's plans announced yesterday to implement further actions to curb tax inversions were likely spurred by the "imminent announcement" of a Pfizer, Allergan merger, Abraham tells investors in a research note. The developments were likely factored into Pfizer and Allergan's assumptions when entering into merger discussions, the analyst adds. He expects a deal to be announced over the near term and keeps a Buy rating on Allergan with a $360 price target. Bloomberg reported last night that Pfizer is nearing an acquisition of Allergan at $370-$380 per share. The Botox maker closed yesterday at $310.38.
06:06 EDTAGNAllergan weekly volatility elevated into reports of near deal with Pfizer
Subscribe for More Information
November 18, 2015
20:00 EDTAGNPfizer nears deal for Allergan at $370-$380 per share, Bloomberg says
Subscribe for More Information
19:00 EDTAGNPfizer nearing acquisition of Allergan at $370-$380 per share, Bloomberg says
Subscribe for More Information
17:00 EDTAGNTreasury Department to release new 'guidance' deterring tax inversions, WSJ says
Subscribe for More Information
09:02 EDTTTEKTetra Tech wins $46M USAID rule of law task order
Subscribe for More Information
November 17, 2015
15:23 EDTRENTRentrak management to meet with William Blair
Subscribe for More Information
11:24 EDTSTOStatoil to exit operations in Alaska
Subscribe for More Information
09:01 EDTTTEKTetra Tech awarded $500M A-E Services contract by U.S. Air Force
Subscribe for More Information
08:39 EDTPXDPioneer Natural most likely large-cap E&P takeover candidate, says Canaccord
Canaccord believes Pioneer Natural (PXD) would be the most likely large cap takeover candidate in the E&P space, but said there is no way a major could make it an immediately accretive asset. The firm also thinks Callon Petroleum (CPE) would be the most likely small to mid-cap acquisition candidate given its high quality core Midland acreage and relatively cheap valuation.
07:51 EDTTOT, STORBC Capital to hold a field trip
European Energy Field Trip travels throughout Europe on November 17-19.
07:47 EDTAGNLeerink sees M&A accelerating for central nervous system assets
Subscribe for More Information
06:31 EDTIBMBerkshire buys more IBM shares, WSJ says
Subscribe for More Information
November 16, 2015
17:10 EDTAGNSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
13:32 EDTAGNCantor helps Moelis clinches advisory role for Pfizer, Reuters reports
Subscribe for More Information
12:33 EDTRENTRentrak management to meet with Needham
Subscribe for More Information
08:07 EDTAGNAllergan reports Phase I/II interim data of Bimatoprost SR IOP therapy
Subscribe for More Information
07:50 EDTIBMUBS to hold a conference
Subscribe for More Information
06:33 EDTAGNPfizer, Allergan deal brings focus on U.S. tax-inversion deals, Reuters says
Pfizer's (PFE) takeover bid for Allergan (AGN) has refocused financial markets over a potential move by the U.S. Treasury Department against tax-inversion deals, Reuters reported Friday. The outlook for such a move remained unclear on Friday, the report says. Reference Link
05:42 EDTIBMXilinx, IBM announce strategic collaboration
IBM (IBM), and Xilinx (XLNX) announced a multi-year strategic collaboration to enable higher performance and energy-efficient data center applications through Xilinx FPGA-enabled workload acceleration on IBM POWER-based systems. IBM and Xilinx, through a private signed agreement and collaboration through the OpenPOWER Foundation, are teaming to develop open acceleration infrastructures, software and middleware to address emerging applications such as machine learning, network functions virtualization, or NFV, genomics, high performance computing, or HPC, and big data analytics. As part of the IBM and Xilinx strategic collaboration, IBM Systems Group developers will create solution stacks for POWER-based servers, storage and middleware systems with Xilinx FPGA accelerators for data center architectures such as OpenStack, Docker, and Spark. IBM will also develop and qualify Xilinx accelerator boards into IBM Power Systems servers. Xilinx is developing and will release POWER-based versions of its leading software defined SDAccel Development Environment and libraries for the OpenPOWER developer community. Additionally, IBM and Xilinx will continue to further utilize IBM's innovative Coherent Accelerator Processor Interface, or CAPI, to deliver accelerated computing value to its clients. CAPI, a unique feature built into the POWER architecture, provides Xilinx and the technology industry at large with the ability to build tightly integrated, coherent solutions right on top of the POWER architecture.
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use